Sarah Davis' daughter Emma was diagnosed with acute lymphoblastic leukaemia (ALL) as a 12-year-old. She writes about the support the family received and the progress Emma has made since finishing treatment
First formed to establish clinical trials in childhood cancer, research has always been an integral part of CCLG’s work. Ellie Ellicott, CCLG Research Communications Executive, tells us more about its research journey and how the experiences of those that matter the most are helping shape future directions.
Supportive care is an area of children’s cancer care that has progressed significantly in recent decades. Dr Bob Phillips and Dr Jess Morgan, members of CCLG’s Supportive Care working group, explain just some of the ways it has improved to help patients and their families cope with their disease and the treatment of it.
Jake Andrade was first diagnosed with leukaemia as a 13-year-old, before relapsing aged 19. Now 21, he tells us about the goals he set to help him through his second treatment and recovery, and how he has published a book to help other young people with cancer
It’s not just the type of treatments that doctors look to improve, but the way they can be delivered so they are safer and more effective, too. We hear from two leading experts on already established advancements in eye cancer treatment, and a developing example of progress in brain tumour therapy.
Naomi Shefford-Thomas, CCLG's Health Information Officer, discusses the importance of accessible information, how it works, and the steps CCLG is taking to make its health resources more inclusive and available to everyone.
Nicky Levent’s son, Sam, was diagnosed with retinoblastoma when he was 18 months old. She explains what it means to her family to raise funds for charities and awareness of childhood cancer, and how it’s helped them.
Child Cancer Smart is a public health intervention aiming to empower both the public and healthcare professionals with knowledge about childhood cancer symptoms. Dr Shaarna Shanmugavadivel, CCLG Research Fellow at the University of Nottingham and part of the project team, tells us more.
Lead investigator Susie Aldiss, a research fellow at the University of Surrey, discusses her research, which is funded by a £92,000 award from CCLG.
